Page last updated: 2024-11-08

biguanides and Astrocytoma, Grade IV

biguanides has been researched along with Astrocytoma, Grade IV in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Roh, TH1
Lee, JH1
Kim, SJ1
Shim, JK1
Park, J1
Yoon, SJ1
Teo, WY1
Kim, SH1
Chang, JH1
Kang, SG1
Barbieri, F1
Bosio, AG1
Pattarozzi, A1
Tonelli, M1
Bajetto, A1
Verduci, I1
Cianci, F1
Cannavale, G1
Palloni, LMG1
Francesconi, V1
Thellung, S1
Fiaschi, P1
Mazzetti, S1
Schenone, S1
Balboni, B1
Girotto, S1
Malatesta, P1
Daga, A1
Zona, G1
Mazzanti, M1
Florio, T1

Other Studies

2 other studies available for biguanides and Astrocytoma, Grade IV

ArticleYear
A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres.
    Journal of neuro-oncology, 2022, Volume: 156, Issue:1

    Topics: Adenosine Triphosphate; Animals; Biguanides; Brain Neoplasms; Cell Line, Tumor; Energy Metabolism; G

2022
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.
    Journal of experimental & clinical cancer research : CR, 2022, Feb-08, Volume: 41, Issue:1

    Topics: Biguanides; Cell Line, Tumor; Chloride Channels; Glioblastoma; Glioma; Humans; Neoplastic Stem Cells

2022